Investigation of MDA-LDL (Malondialdehyde-Modified Low-Density Lipoprotein) as a Prognostic Marker for Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus
Clinica Chimica Acta - Netherlands
doi 10.1016/j.cca.2015.08.003
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2015
Authors
Publisher
Elsevier BV